r2rtf
The clinical-report table engine learned Chinese, then learned to leave RTF entirely
Comparison · Analytics
DataSpaceR vs pharmaverseadam
A side-by-side editorial comparison of DataSpaceR and pharmaverseadam — release velocity, themes, recent moves, and the top alternatives to consider.
DataSpaceR vs pharmaverseadam: at a glance
What is DataSpaceR?
DataSpaceR's 1.0.0 rebuilt its query API and opened up HIV antibody sequence data.
The R client for the CAVD DataSpace reached 1.0.0 in July 2026 after five years of small fixes. The release removed the mAb grid filtering and view methods in favour of filtering an availableMabs object with data.table syntax, applied that pattern to every query method, and added a class for querying DAASH, the Database of Annotated Antibody Sequences for HIV-1. The August patch restored the LANL monoclonal-antibody metadata requests and batched BCR sequence queries.
What is pharmaverseadam?
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
DataSpaceR vs pharmaverseadam: editorial side-by-side
DataSpaceR
2.5ANALYTICS
DataSpaceR's 1.0.0 rebuilt its query API and opened up HIV antibody sequence data.
◆ Current state
The R client for the CAVD DataSpace reached 1.0.0 in July 2026 after five years of small fixes. The release removed the mAb grid filtering and view methods in favour of filtering an availableMabs object with data.table syntax, applied that pattern to every query method, and added a class for querying DAASH, the Database of Annotated Antibody Sequences for HIV-1. The August patch restored the LANL monoclonal-antibody metadata requests and batched BCR sequence queries.
◆ Where it's heading
The package is converging on one query idiom — build a filtered object, then fetch — instead of per-domain grid methods, and each class now accepts multiple studies or antibodies rather than one. The 1.0.1 patch suggests the rewrite dropped functionality that users noticed, and it was put back rather than redesigned.
◆ Prediction
With DAASH access in place and the query surface unified, the next work is most likely more sequence-domain coverage and follow-up fixes to the batched query paths introduced in 1.0.1.
pharmaverseadam
0.0ANALYTICS
pharmaverseadam is the pharmaverse's test-data mirror, and it now covers neurology.
◆ Current state
pharmaverseadam ships pre-built ADaM datasets generated by running the admiral family's own templates, so package authors and trainers have realistic analysis data without writing derivations first. The 1.3.0 release pulls in `ADAPET`, `ADTPET` and `ADNV` from admiralneuro and an anti-drug antibody dataset from admiral itself, and regenerates everything against current versions of seven upstream packages. Variables are now ordered and grouped to ADaM IG structure.
◆ Where it's heading
Coverage tracks the pharmaverse's own therapeutic-area expansion with a lag of one release: pediatrics arrived in 1.1.0, metabolic in 1.2.0, neurology in 1.3.0. The other consistent thread is a slow move off development versions — 1.1.0 and 1.2.0 both had to pin unreleased upstream builds to get working templates, while 1.3.0 cites released versions throughout. Reorganising the reference page by therapeutic area is the same maturation showing up in documentation.
◆ Prediction
Expect the next release to follow the established pattern — a refresh against current upstream versions plus datasets from whichever admiral therapeutic-area package reaches a stable release next.
Alternatives to DataSpaceR and pharmaverseadam
Other Analytics products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either DataSpaceR or pharmaverseadam.
DoseFinding
New stewardship at openpharma, then two releases adding the methods MCP-Mod was missing
webmockr
The stubbing library added httr2 support, then spent a year cutting itself free of everything else
crul
crul took mocking back from webmockr and made it a property of the client itself
dendroNetwork
Six releases, six identical bodies — the feed carries the package abstract instead of release notes
chattr
chattr deleted every LLM integration it had written and outsourced the lot to ellmer
See all DataSpaceR alternatives → · See all pharmaverseadam alternatives →
Recent activity from DataSpaceR and pharmaverseadam
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
- 9d agoDataSpaceRLANL metadata requests restored and BCR queries batched
- 1mo agoDataSpaceRQuery API rebuilt and DAASH antibody sequence access added ⚡
- 5mo agopharmaverseadamNeurology and anti-drug antibody datasets added
- 11mo agopharmaverseadamMetabolic therapeutic area datasets arrive
- 1y agoDataSpaceRFixes for antibody and donor queries
- 1y agoDataSpaceRLANL metadata added to neutralising-antibody pulls
- 1y agopharmaverseadamPediatric ADVS added in an ad-hoc refresh
- 2y agopharmaverseadam1.0 declares the dataset collection stable
- 2y agopharmaverseadamFirst release of the ADaM dataset collection
- 4y agoDataSpaceRSession fix for CDS reports and snake-case bindings
Frequently asked questions
What is the difference between DataSpaceR and pharmaverseadam?
They serve adjacent needs but don't currently overlap on shipped themes. DataSpaceR is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Is DataSpaceR better than pharmaverseadam?
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. DataSpaceR is currently shipping more aggressively (velocity 2.5 vs 0.0), with 0 editorial sparks in the last 30 days against 0. For your specific use case, the alternatives sections above list other Analytics products to evaluate alongside.
What are the best alternatives to DataSpaceR?
Top DataSpaceR alternatives in Analytics are ranked by recent ship velocity. Browse the "DataSpaceR alternatives" section above for the current picks, or visit /alternatives/dataspacer for the full list with editorial commentary on each.
What are the best alternatives to pharmaverseadam?
Top pharmaverseadam alternatives in Analytics are ranked by recent ship velocity. Browse the "pharmaverseadam alternatives" section above for the current picks, or visit /alternatives/pharmaverseadam for the full list with editorial commentary on each.